ImmuneOncia Therapeutics Statistics

Total Valuation

KOSDAQ:424870 has a market cap or net worth of KRW 379.14 billion. The enterprise value is 367.91 billion.

Market Cap	379.14B
Enterprise Value	367.91B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:424870 has 73.91 million shares outstanding. The number of shares has increased by 1,117.38% in one year.

Current Share Class	73.91M
Shares Outstanding	73.91M
Shares Change (YoY)	+1,117.38%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	579.24
PB Ratio	19.52
P/TBV Ratio	26.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-64.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.94

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.00.

Current Ratio	3.06
Quick Ratio	3.00
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-1,819.29

Financial Efficiency

Return on equity (ROE) is -22.97% and return on invested capital (ROIC) is -31.66%.

Return on Equity (ROE)	-22.97%
Return on Assets (ROA)	-26.25%
Return on Invested Capital (ROIC)	-31.66%
Return on Capital Employed (ROCE)	-63.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5,281.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.29
Average Volume (20 Days)	697,434

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:424870 had revenue of KRW 654.54 million and -5.69 billion in losses. Loss per share was -101.00.

Revenue	654.54M
Gross Profit	643.42M
Operating Income	-12.60B
Pretax Income	-5.69B
Net Income	-5.69B
EBITDA	-11.55B
EBIT	-12.60B
Loss Per Share	-101.00

Full Income Statement

Balance Sheet

The company has 11.33 billion in cash and 95.06 million in debt, giving a net cash position of 11.23 billion or 151.97 per share.

Cash & Cash Equivalents	11.33B
Total Debt	95.06M
Net Cash	11.23B
Net Cash Per Share	151.97
Equity (Book Value)	19.42B
Book Value Per Share	344.97
Working Capital	13.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.66 billion and capital expenditures -86.87 million, giving a free cash flow of -14.75 billion.

Operating Cash Flow	-14.66B
Capital Expenditures	-86.87M
Free Cash Flow	-14.75B
FCF Per Share	-199.58

Full Cash Flow Statement

Margins

Gross Margin	98.30%
Operating Margin	-1,924.80%
Pretax Margin	-868.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:424870 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,117.38%
Shareholder Yield	n/a
Earnings Yield	-1.50%
FCF Yield	-3.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:424870 has an Altman Z-Score of -6.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.87
Piotroski F-Score	1